HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsuyoshi Yokoi Selected Research

Embryonal Carcinoma

4/2003Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines.
6/2002Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsuyoshi Yokoi Research Topics

Disease

25Chemical and Drug Induced Liver Injury
10/2021 - 10/2009
16Neoplasms (Cancer)
01/2022 - 11/2002
12Inflammation (Inflammations)
10/2020 - 02/2011
9Hepatocellular Carcinoma (Hepatoma)
08/2011 - 02/2002
8Wounds and Injuries (Trauma)
04/2021 - 10/2012
8Necrosis
10/2020 - 06/2008
7Cholestasis
10/2021 - 05/2007
7Breast Neoplasms (Breast Cancer)
10/2009 - 06/2002
6Acute Kidney Injury (Acute Renal Failure)
06/2019 - 01/2016
6Liver Diseases (Liver Disease)
12/2017 - 12/2005
5Hepatitis
10/2020 - 12/2005
5Infections
05/2011 - 08/2007
4Heart Failure
03/2021 - 08/2018
4Carcinoma (Carcinomatosis)
01/2021 - 06/2002
4Carcinogenesis
05/2013 - 05/2004
4Adenocarcinoma
07/2006 - 06/2002
3Myocarditis (Carditis)
01/2020 - 01/2018
3Renal Insufficiency (Renal Failure)
06/2019 - 09/2010
3Rhabdomyolysis
06/2019 - 07/2018
3Drug-Related Side Effects and Adverse Reactions
01/2018 - 01/2012
3Fatty Liver
01/2017 - 01/2002
3Leukemia
01/2016 - 01/2012
3Lung Neoplasms (Lung Cancer)
04/2010 - 08/2005
2Diabetes Mellitus
11/2019 - 12/2005
2Type 2 Diabetes Mellitus (MODY)
12/2018 - 01/2017
2Anaphylaxis (Anaphylactic Shock)
01/2018 - 12/2014
2Drug Hypersensitivity (Drug Allergy)
01/2018 - 01/2017
2Fibrosis (Cirrhosis)
01/2018 - 01/2012
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2018 - 01/2018
2Ischemia
01/2018 - 10/2012
2Non-alcoholic Fatty Liver Disease
12/2017 - 01/2012
2Liver Failure
01/2016 - 09/2004
2Alzheimer Disease (Alzheimer's Disease)
08/2015 - 08/2005
2Body Weight (Weight, Body)
02/2015 - 01/2009
2Cardiovascular Diseases (Cardiovascular Disease)
10/2013 - 09/2011
2Methemoglobinemia
06/2013 - 11/2012
2Prostatic Neoplasms (Prostate Cancer)
06/2012 - 07/2009
2Hypoxia (Hypoxemia)
05/2012 - 08/2009
2Leukopenia
06/2007 - 06/2005
2Renal Cell Carcinoma (Grawitz Tumor)
04/2003 - 06/2002
2Embryonal Carcinoma
04/2003 - 06/2002
1Leiomyosarcoma
01/2022
1Cardiomyopathies (Cardiomyopathy)
02/2020
1Polyuria
01/2020

Drug/Important Bio-Agent (IBA)

19MicroRNAs (MicroRNA)IBA
10/2021 - 10/2009
13Biomarkers (Surrogate Marker)IBA
10/2021 - 09/2009
11Proteins (Proteins, Gene)FDA Link
04/2021 - 02/2005
11Messenger RNA (mRNA)IBA
11/2019 - 04/2003
7EnzymesIBA
04/2018 - 02/2005
4Troglitazone (Rezulin)FDA Link
11/2019 - 02/2002
4Glutathione (Reduced Glutathione)IBA
01/2019 - 07/2015
4GlucuronidesIBA
01/2018 - 12/2014
4Alanine Transaminase (SGPT)IBA
01/2017 - 08/2007
4Flutamide (Eulexin)FDA LinkGeneric
10/2012 - 07/2009
4Cytochrome P-450 CYP3AIBA
01/2012 - 06/2005
4NicotineFDA Link
04/2007 - 11/2002
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2019 - 07/2018
3buthionineIBA
01/2019 - 01/2016
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2018 - 11/2013
3Carbamazepine (Tegretol)FDA LinkGeneric
01/2018 - 11/2012
3Phenytoin (Dilantin)FDA LinkGeneric
01/2018 - 09/2007
3Acetaminophen (Paracetamol)FDA LinkGeneric
08/2014 - 06/2008
3XenobioticsIBA
01/2013 - 09/2011
3PhenacetinIBA
11/2012 - 09/2010
3Small Interfering RNA (siRNA)IBA
04/2010 - 08/2007
3Estrogens (Estrogen)FDA Link
09/2005 - 05/2004
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2021
2CytokinesIBA
10/2020 - 02/2015
2RNA (Ribonucleic Acid)IBA
12/2019 - 01/2012
22,4-thiazolidinedione (thiazolidinedione)IBA
11/2019 - 01/2017
2Creatine Kinase (Creatine Phosphokinase)IBA
06/2019 - 05/2019
2MyoglobinIBA
05/2019 - 01/2019
2LipidsIBA
12/2018 - 01/2012
2zomepirac (Zomax)IBA
01/2018 - 01/2016
2Carboxylic AcidsIBA
01/2018 - 01/2017
2Analgesics (Analgesic Drugs)IBA
11/2012 - 04/2007
2Cytochrome P-450 CYP1A2 (CYP1A2)IBA
11/2012 - 09/2003
2TamoxifenFDA LinkGeneric
10/2012 - 01/2012
2Diclofenac (SR 38)FDA LinkGeneric
10/2012 - 05/2011
2Androgen Antagonists (Antiandrogens)IBA
06/2012 - 07/2009
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
05/2012 - 04/2003
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2008 - 09/2004
2BilirubinIBA
05/2007 - 04/2007
2LuciferasesIBA
05/2004 - 05/2003
1BI 2536IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1prexasertibIBA
01/2022
1Oxygen (Dioxygen)IBA
03/2021
1Transaminases (Aminotransferases)IBA
10/2020
1RyanodineIBA
10/2020
1Concanavalin AIBA
10/2020
1AnthracyclinesIBA
02/2020
13-dinitrobenzeneIBA
01/2020
1DobutamineFDA LinkGeneric
01/2020

Therapy/Procedure

18Drug Therapy (Chemotherapy)
04/2021 - 02/2005
4Therapeutics
01/2022 - 08/2005
3Extracorporeal Membrane Oxygenation
01/2020 - 08/2018
2Ligation
01/2018 - 01/2012
1Heart-Assist Devices
02/2020
1Intra-Aortic Balloon Pumping
01/2020